Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novartis
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Outpatients ≥ 50 kg (110 lb) of weight.
A diagnosis of epilepsy (≥ 2 years prior to screening) with partial seizures with or without secondarily generalized seizures.
Uncontrolled partial seizures despite having been treated with at least two different antiepileptic drugs (AEDs) within the last 2 years prior to screening.
At least 4 partial seizures during the 4-week baseline period and at least 4 partial seizures during the 4 weeks prior to the baseline period.
Cohort 1 patients must be receiving stable treatment with 1 or a maximum of 2 AEDs.Cohort 2 patients must be receiving stable treatment with 1, 2, or 3 AEDs.
You may not be if
Presence of only non-motor simple partial seizures.
History of psychogenic seizures.
Absences, myoclonic seizures e.g. in the context of primary generalized epilepsy.
Previous history of Lennox-Gastaut syndrome.
Status epilepticus or seizure clusters, according to the judgement of the investigator, occurring within 52 weeks prior to randomization.
Pregnant or nursing (lactating) women.
Clareo Health | Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures
